Perceived harms and benefits of tobacco, marijuana, and electronic vaporizers among young adults in Colorado: implications for health education and research

Addiction

Volumn 112, Issue 10, 2017, Pages 1821-1829

  Popova, Lucy ^a   McDonald, Emily Anne ^b   Sidhu, Sohrab ^c   Barry, Rachel ^d   Richers Maruyama, Tracey A ^e   Sheon, Nicolas M ^f   Ling, Pamela M ^f  

^a GEORGIA STATE UNIVERSITY   (United States)

^b JOHN JAY COLLEGE OF CRIMINAL JUSTICE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e DENVER PUBLIC HEALTH   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cannabis; electronic cigarettes; perceived benefits; perceived harm; qualitative research; tobacco

Indexed keywords

ADOLESCENT; ADULT; ATTITUDE TO HEALTH; CANNABIS SMOKING; COLORADO; ELECTRONIC CIGARETTE; FEMALE; HEALTH EDUCATION; HUMAN; INTERVIEW; MALE; PSYCHOLOGY; RESEARCH; SMOKING; YOUNG ADULT;

ADOLESCENT; ADULT; COLORADO; ELECTRONIC NICOTINE DELIVERY SYSTEMS; FEMALE; HEALTH EDUCATION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERVIEWS AS TOPIC; MALE; MARIJUANA SMOKING; RESEARCH; TOBACCO SMOKING; YOUNG ADULT;

EID: 85019723707     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.13854     Document Type: Article

References (52)

1. Gravely S., Fong G. T., Cummings K. M., Yan M., Quah A. C. K., Borland R. et al. Awareness, trial, and current use of electronic cigarettes in 10 countries: findings from the ITC project. Int J Environ Res Public Health 2014; 11: 11691–11704.
2. Schauer G. L., King B. A., Bunnell R. E., Promoff G., McAfee T. A. Toking, vaping, and eating for health or fun: marijuana use patterns in adults, US, 2014. Am J Prev Med 2016; 50: 1–8.
3. Smith J. Marijuana legislation coming to Canada next spring. 20 April 2016. Available at: https://www.thestar.com/news/canada/2016/04/20/marijuana-legislation-coming-to-canada-next-spring.html (accessed 20 June 2016) (Archived at http://www.webcitation.org/6qPYSNlv5 on 12 May 2017).
4. Hall W., Weier M. Assessing the public health impacts of legalizing recreational cannabis use in the USA. Clin Pharmacol Ther 2015; 97: 607–615.
5. Hindocha C., Freeman T. P., Ferris J. A., Lynskey M. T., Winstock A. R. No smoke without tobacco: a global overview of cannabis and tobacco routes of administration and their association with intention to quit. Front Psychol 2016; 7: 104.
6. United States Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Center for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office of Smoking and Health; 2014.
7. World Health Organization. Tobacco Free Initiative. Information on Global Tobacco Use. Available at: http://www.who.int/tobacco/resources/publications/TFI%20primer-English.pdf (accessed 30 June 2016) (Archived at http://www.webcitation.org/6qPZ6d9cw on 12 May 2017).
8. Nutt D. J., King L. A., Phillips L. D. Drug harms in the UK: a multicriteria decision analysis. Lancet 2010; 376: 1558–1565.
9. Volkow N. D., Baler R. D., Compton W. M., Weiss S. R. Adverse health effects of marijuana use. N Engl J Med 2014; 370: 2219–2227.
10. Hall W., Solowij N. Adverse effects of cannabis. Lancet 1998; 352: 1611–1616.
11. Bloom J. W., Kaltenborn W. T., Paoletti P., Camilli A., Lebowitz M. D. Respiratory effects of non-tobacco cigarettes. BMJ (Clin Res Ed) 1987; 295: 1516–1518.
12. Tashkin D. P., Fligiel S., Wu T.-C., Gong H., Barbers R. G., Coulson A. H. et al. Effects of habitual use of marijuana and/or cocaine on the lung. NIDA Res Monogr 1990; 99: 63–87.
13. Callaghan R. C., Allebeck P., Sidorchuk A. Marijuana use and risk of lung cancer: a 40-year cohort study. Cancer Causes Control 2013; 24: 1811–1820.
14. Tashkin D. Is frequent marijuana smoking harmful to health? West J Med 1993; 158: 635.
15. Thomas G., Kloner R. A., Rezkalla S. Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: what cardiologists need to know. Am J Cardiol 2014; 113: 187–190.
16. Caldicott D. G., Holmes J., Roberts-Thomson K. C., Mahar L. Keep off the grass: marijuana use and acute cardiovascular events. Eur J Emerg Med 2005; 12: 236–244.
17. Bachs L., Mørland H. Acute cardiovascular fatalities following cannabis use. Forensic Sci Int 2001; 124: 200–203.
18. Patton G. C., Coffey C., Carlin J. B., Degenhardt L., Lynskey M., Hall W. Cannabis use and mental health in young people: cohort study. BMJ 2002; 325: 1195–1198.
19. Solowij N., Stephens R. S., Roffman R. A., Babor T., Kadden R., Miller M. et al. Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA 2002; 287: 1123–1131.
20. Meier M. H., Caspi A., Ambler A., Harrington H., Houts R., Keefe R. S. E. et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci 2012; 109: E2657–E2E64.
21. Peters E. N., Budney A. J., Carroll K. M. Clinical correlates of co-occurring cannabis and tobacco use: a systematic review. Addiction 2012; 107: 1404–1417.
22. Grana R., Benowitz N., Glantz S. A. E-cigarettes: a scientific review. Circulation 2014; 129: 1972–1986.
23. Berg C. J., Stratton E., Schauer G. L., Lewis M., Wang Y., Windle M. et al. Perceived harm, addictiveness, and social acceptability of tobacco products and marijuana among young adults: marijuana, hookah, and electronic cigarettes win. Subst Use Misuse 2015; 50: 79–89.
24. Loflin M., Earleywine M. A new method of cannabis ingestion: the dangers of dabs? Addict Behav 2014; 39: 1430–1433.
25. Calabria B., Swift W., Slade T., Hall W., Copeland J. The perceived health risks of cannabis use in an Australian household survey. Drug Alcohol Rev 2012; 31: 809–812.
26. Hall W., Nelson J. Public Perceptions of the Health and Psychological Consequences of Cannabis Use. Canberra: National Task Force on Cannabis: AGPS; 1995.
27. Hall W., Nelson J. Correlates of the perceived health risks of marijuana use among Australian adults. Drug Alcohol Rev 1996; 15: 137–143.
28. Roditis M. L., Halpern-Felsher B. Adolescents’ perceptions of risks and benefits of conventional cigarettes, e-cigarettes, and marijuana: a qualitative analysis. J Adolesc Health 2015; 57: 179–185.
29. Substance Abuse and Mental Health Services Administration. Results From the 2013 National Survey on Drug Use and Health: Detailed Tables. Rockville, MD: Substance Abuse and Mental Health Services Administration, US Department of Health and Human Services; 2013.
30. Substance Abuse and Mental Health Services Administration. 2012–2013 National Survey on Drug Use and Health: Model-Based Prevalence Estimates (50 States and the District of Columbia). Rockville, MD: Substance Abuse and Mental Health Services Administration, US Department of Health and Human Services; 2015.
31. Braun V., Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006; 3: 77–101.
32. Boyatzis R. E. Transforming Qualitative Information: Thematic Analysis and Code Development. Thousand Oaks, CA: Sage; 1998.
33. Neale J., Allen D., Coombes L. Qualitative research methods within the addictions. Addiction 2005; 100: 1584–1593.
34. Lynskey M. T., Hindocha C., Freeman T. P. Legal regulated markets have the potential to reduce population levels of harm associated with cannabis use. Addiction 2016; 111: 2090–2096.
35. Philip Morris International. What are Reduced Risk Products (RRPs). 2016. Available at: https://www.pmiscience.com/welcome/what-are-reduced-risk-products-rrps-ref-1 (accessed 20 June 2016) (Archived at http://www.webcitation.org/6qPZIs2Td on 12 May 2017).
36. US Food and Drug Administration. Swedish Match North America, Inc. MRTP Applications. 2014. Available at: http://www.accessdata.fda.gov/Static/widgets/tobacco/SMNA_MRTPA_FDA-2014-N-1051.html (accessed 20 June 2016) (Archived at http://www.webcitation.org/6qPZOjqw5 on 12 May 2017).
37. United States Department of Health and Human Services. Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act; Restrictions on the Sale and Distribution of Tobacco Products and Required Warning Statements for Tobacco Products; Final Rule (21 CFR Parts 1100, 1140, and 1143). 28974-9106. Rockville, MD: Department of Health and Human Services; 2016.
38. Czoli C. D., Hammond D. Cigarette packaging: youth perceptions of ‘natural’ cigarettes, filter references, and contraband tobacco. J Adolesc Health 2014; 54: 33–39.
39. Bialous S. A., Yach D. Whose standard is it, anyway? How the tobacco industry determines the International Organization for Standardization (ISO) standards for tobacco and tobacco products. Tob Control 2001; 10: 96–104.
40. Colorado Department of Public Health and Environment. Good to Know: Marijuana 101. Available at: http://goodtoknowcolorado.com/before-you-use/marijuana-101 (accessed 20 June 2016) (Archived at http://www.webcitation.org/6qPZQtfSC on 12 May 2017).
41. Wang X., Derakhshandeh R., Liu J., Narayan S., Nabavizadeh P., Le S. et al. One minute of marijuana secondhand smoke exposure substantially impairs vascular endothelial function. J Am Heart Assoc 2016; 5: e003858.
42. Centers for Disease Control and Prevention Best Practices for Comprehensive Tobacco Control Programs. Atlanta, GA: US Department of Health and Human Services; 2014.
43. US Food and Drug Administration (FDA). Chemicals in Every Tobacco Plant. Silver Spring, MD: FDA; 2017.
44. US Food and Drug Administration (FDA). The Real Cost Campaign. 2016. Available at: http://www.fda.gov/TobaccoProducts/PublicHealthEducation/PublicEducationCampaigns/TheRealCostCampaign/default.htm (accessed 20 June 2016) (Archived at http://www.webcitation.org/6qPZVGK3s on 12 May 2017).
45. Chaudhry H. J., Hengerer A. S., Snyder G. B. Medical board expectations for physicians recommending marijuana. JAMA 2016; 316: 577–578.
46. McDaniel P. A., Malone R. E. ‘I always thought they were all pure tobacco’: American smokers’ perceptions of ‘natural’ cigarettes and tobacco industry advertising strategies. Tob Control 2007; 16: e7.
47. Byron M. J., Baig S. A., Moracco K. E., Brewer N. T. Adolescents’ and adults’ perceptions of ‘natural’, ‘organic’ and ‘additive-free’ cigarettes, and the required disclaimers. Tob Control 2015 25: 517–20.
48. Sterling K. L., Fryer C. S., Fagan P. The most natural tobacco used: a qualitative investigation of young adult smokers’ risk perceptions of flavored little cigars and cigarillos. Nicotine Tob Res 2015 18: 827–833.
49. Council Regulation (EC) No. 834/2007 of 28 June 2007 on organic production and labelling of organic products and repealing Regulation (EEC) No. 2092/91. Off J Eur Union 2007.
50. Krasny L. T. Labeling Requirements for Beverages in the USA. In: In: Wilson T, Temple NJ, editors. Beverage Impacts on Health and Nutrition. New York, NY: Springer; 2016, pp. 331–347.
51. Thrasher J. F., Murukutla N., Pérez-Hernández R., Alday J., Arillo-Santillán E., Cedillo C. et al. Linking mass media campaigns to pictorial warning labels on cigarette packages: a cross-sectional study to evaluate effects among Mexican smokers. Tob Control 2012; 104: e11–e30.
52. Brennan E., Durkin S. J., Cotter T., Harper T., Wakefield M. A. Mass media campaigns designed to support new pictorial health warnings on cigarette packets: evidence of a complementary relationship. Tob Control 2011; 20: 412–418.